tiprankstipranks
LifeMD (LFMD)
NASDAQ:LFMD
US Market
Holding LFMD?
Track your performance easily

LifeMD (LFMD) Earnings Date & Reports

493 Followers

Earnings Data

Report Date
Apr 08, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-$0.05
Last Year’s EPS
-$0.19
Same Quarter Last Year
Based on 6 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 07, 2024
|
% Change Since: -1.75%
|
Next Earnings Date:Apr 08, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in LifeMD's telehealth business, with significant revenue growth, improved profitability, and strategic expansions in pharmacy operations. However, challenges remain with GLP-1 therapy coverage and maintaining growth in WorkSimpli's subscriber base. Despite these issues, the overall sentiment leans positive due to robust growth and financial results.
Company Guidance
During LifeMD's Q3 2024 earnings call, the company provided several key metrics and updates regarding its performance and future guidance. The telehealth revenue for the quarter grew by an impressive 65% compared to the previous quarter, with telehealth stand-alone profitability seeing a significant increase in adjusted EBITDA, which rose by 200% sequentially to $2.5 million, surpassing the guidance range of $500,000 to $1.5 million. Total revenues for the quarter reached $53.4 million, marking a 38% increase from the previous year. The company reported a consolidated gross margin of 90.6%, with a gross profit of $48.4 million, representing a 43% year-over-year increase. Active telehealth subscribers grew by 30% year-over-year, totaling approximately 269,000, while the WorkSimpli active subscribers saw a 6% contraction to 161,000. LifeMD raised its telehealth revenue guidance for 2024 to between $151 million and $152 million and increased its stand-alone telehealth adjusted EBITDA guidance to a range of $6 million to $7 million. The company also highlighted its newly opened 22,500-square-foot National Pharmacy and plans for contracting with private and government payer programs to further enhance affordability and accessibility.
Significant Telehealth Revenue Growth
Telehealth revenue grew by 65% compared to the prior year, with telehealth stand-alone profitability showing a 200% sequential increase in adjusted EBITDA to $2.5 million.
Expansion of National Pharmacy Operations
LifeMD opened a 22,500 square foot national pharmacy in Pennsylvania, expected to be accretive in 2025, improving patient experience and product delivery times.
Strong Subscriber Growth
Telehealth subscriber growth was strong with a 30% year-over-year increase to approximately 269,000 active subscribers at the end of the quarter.
Record Gross Margin
Consolidated gross margin reached a record 90.6%, up 300 basis points from the previous year, with a gross profit increase of 43% from the year-ago period.
Positive Cash Flow Generation
LifeMD generated over $6.2 million of cash flow from operations during the third quarter and exited the quarter with $37.6 million in cash.
---

LifeMD (LFMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LFMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 08, 20252024 (Q4)
-0.05 / -
-0.19
Nov 07, 20242024 (Q3)
-0.12 / -0.14
-0.230.00% (+0.06)
Aug 07, 20242024 (Q2)
-0.14 / -0.19
0.05-480.00% (-0.24)
May 08, 20242024 (Q1)
-0.15 / -0.19
0.06-416.67% (-0.25)
Mar 11, 20242023 (Q4)
-0.14 / -0.12
-0.470.00% (+0.28)
Nov 08, 20232023 (Q3)
-0.09 / -0.20
-0.03-566.67% (-0.17)
Aug 09, 20232023 (Q2)
-0.10 / 0.05
-0.22122.73% (+0.27)
May 12, 20232023 (Q1)
-0.16 / 0.06
-0.25124.00% (+0.31)
Mar 22, 20232022 (Q4)
-0.18 / -0.40
-0.29-37.93% (-0.11)
Nov 10, 20222022 (Q3)
-0.21 / -0.03
-0.3691.67% (+0.33)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

LFMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$5.13$5.85+14.04%
Aug 07, 2024$5.37$5.22-2.79%
May 08, 2024$12.33$9.30-24.57%
Mar 11, 2024$7.95$8.38+5.41%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does LifeMD (LFMD) report earnings?
LifeMD (LFMD) is schdueled to report earning on Apr 08, 2025, TBA Not Confirmed.
    What is LifeMD (LFMD) earnings time?
    LifeMD (LFMD) earnings time is at Apr 08, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LFMD EPS forecast?
          LFMD EPS forecast for the fiscal quarter 2024 (Q4) is -$0.05.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis